Literature DB >> 1612106

Feeding pattern studies suggest that d-fenfluramine and sertraline specifically enhance the state of satiety in rats.

G Grignaschi1, J C Neill, A Petrini, S Garattini, R Samanin.   

Abstract

The effects of d-fenfluramine (1.5 mg/kg) and sertraline (10 mg/kg), administered intraperitoneally once daily for seven days were studied on feeding parameters of rats over various periods. On the first day of treatment both drugs markedly reduced meal size and meal duration during the first hour and, to a lesser extent, the first 4 h. No effects were seen later. The size and duration of eating bouts were also markedly reduced by both drugs in the first hour. There was no significant effect of either drug on meal frequency in any period. Only d-fenfluramine significantly reduced the rate of eating within 4 h from the start of testing. Sertraline, but not d-fenfluramine, markedly increased locomotor activity in the first 4 h after the start of testing. The d-fenfluramine effect on eating rate disappeared by the second day whereas total intake and meal size were still reduced on day five. By days six and seven however the d-fenfluramine-treated rats did not differ from the controls. During the seven-day treatment sertraline always reduced total food eaten and meal size but caused only transient changes of locomotor activity and eating rate. Since the effects of d-fenfluramine and sertraline on meal size and food intake could be separated from the effects on eating rate and arousal, it appears that at appropriate doses these drugs specifically increase the satiating effect of food. Tolerance to this effect appears to develop more rapidly for d-fenfluramine than for sertraline.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612106     DOI: 10.1016/0014-2999(92)90520-e

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Role of serotonin receptors in the effect of sertraline on feeding behaviour.

Authors:  G Grignaschi; R Samanin
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Behavioural evidence that d-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype.

Authors:  S P Vickers; P G Clifton; C T Dourish
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

3.  Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients.

Authors:  V Ricca; E Mannucci; M Di Bernardo; S M Rizzello; P L Cabras; C M Rotella
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

4.  Leptin and post-prandial satiety: acute central leptin more potently reduces meal frequency than meal size in the rat.

Authors:  Eric P Zorrilla; Koki Inoue; Glenn R Valdez; Antoine Tabarin; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2004-07-27       Impact factor: 4.530

Review 5.  Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.

Authors:  R Davis; D Faulds
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

Review 6.  What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials.

Authors:  David J Heal; Jane Gosden
Journal:  Int J Obes (Lond)       Date:  2022-01-07       Impact factor: 5.551

7.  Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats.

Authors:  G Grignaschi; B Mantelli; C Fracasso; M Anelli; S Caccia; R Samanin
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

Review 8.  Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.

Authors:  David J Heal; Sharon L Smith
Journal:  J Psychopharmacol       Date:  2021-07-28       Impact factor: 4.562

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.